A wholly nutritional 'multifocal angiostatic therapy' for control of disseminated cancer

M F McCarty1

  • 1Pantox Laboratories, San Diego, California 92129, USA.

Medical Hypotheses
|June 5, 2003
PubMed

Insights

Nutritional strategies, including a vegan diet and specific supplements, show promise for a multifocal angiostatic therapy (MAT) to inhibit cancer growth. This approach targets tumor angiogenesis through diet and supplements, offering a complementary strategy to conventional treatments.

Area of Science:

  • Oncology
  • Nutritional Science
  • Molecular Biology

Background:

  • Inoperable cancer treatment focuses on inhibiting tumor-evoked angiogenesis.
  • Nutritional measures are increasingly recognized for their potential to slow angiogenesis.
  • Combining complementary angiostatic strategies may lead to effective multifocal angiostatic therapy (MAT).

Purpose of the Study:

  • To explore the potential of a nutritionally based multifocal angiostatic therapy (MAT) for cancer treatment.
  • To identify specific dietary and supplemental interventions that inhibit tumor angiogenesis.
  • To propose a provisional protocol for a MAT combining various nutritional measures.

Main Methods:

  • Reviewing evidence for nutritional interventions targeting angiogenesis.
  • Discussing the mechanisms of action for a vegan diet, fish oil, selenium, green tea polyphenols, glycine, and zinc.
  • Considering copper depletion via tetrathiomolybdate or zinc supplementation.
  • Evaluating the potential role of COX-2 inhibitors.

Main Results:

  • A vegan diet may down-regulate IGF-I activity.
  • Omega-3 fish oil can inhibit VEGF receptor (Flk-1) and suppress pro-angiogenic eicosanoids.
  • Selenium and green tea polyphenols inhibit VEGF production and endothelial responsiveness.
  • Glycine may inhibit endothelial cell mitosis.
  • Copper depletion and zinc supplementation show potential for angiostatic effects.

Conclusions:

  • A provisional MAT protocol can be devised using a vegan diet and supplements like fish oil, selenium, green tea polyphenols, glycine, and zinc.
  • Nutritional interventions offer a complementary approach to conventional cancer therapies by targeting angiogenesis.
  • Further research into nutritionally based MAT is warranted for clinical application.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...